| Literature DB >> 25689566 |
Yin-Di Su1,2, Tzu-Rong Su3,4, Zhi-Hong Wen5, Tsong-Long Hwang6, Lee-Shing Fang7, Jih-Jung Chen8, Yang-Chang Wu9,10,11,12, Jyh-Horng Sheu13, Ping-Jyun Sung14,15,16,17,18.
Abstract
Two new briarane-type diterpenoids, briarenolides K (1) and L (2), were isolated from an octocoral identified as Briareum sp. The structures of new briaranes 1 and 2 were elucidated by spectroscopic methods. In the in vitro anti-inflammatory effects test, briaranes 1 and 2 were found to significantly inhibit the accumulation of the pro-inflammatory iNOS protein of the lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cells.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25689566 PMCID: PMC4344617 DOI: 10.3390/md13021037
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Scheme 1The octocoral Briareum sp. and the structures of briarenolides K (1) and L (2).
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and 1H–1H COSY and HMBC correlations for briarane 1.
| Position | δH ( | δC, Multiple | 1H–1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 39.2, C | |||
| 2 | 3.12 br d (9.6) | 75.9, CH | H-3, OH-2 | n. o. a |
| 3 | 3.31 dd (9.6, 4.0) | 60.3, CH | H-2, H-4 | C-1 |
| 4 | 4.09 br s | 58.2, CH | H-3, H-6 | n .o. |
| 5 | 136.3, C | |||
| 6 | 5.81 dddd (9.2, 1.2, 0.8, 0.8) | 122.9, CH | H-4, H-7, H2-16 | C-16 |
| 7 | 5.32 d (9.2) | 76.6, CH | H-6 | C-5, -8 |
| 8 | 81.8, C | |||
| 9 | 5.35 d (8.4) | 69.3, CH | H-10 | C-8, -17, acetate carbonyl |
| 10 | 1.82 dd (8.4, 2.4) | 36.8, CH | H-9, H-11 | C-1, -2, -8, -9, -11, -15, -20 |
| 11 | 2.17 m | 36.5, CH | H-10, H-12, H3-20 | n. o. |
| 12 | 4.94 d (4.8) | 71.7, CH | H-11, H-13 | C-10, -11, -13, -14, -20, |
| acetate carbonyl | ||||
| 13 | 3.27 d (4.0) | 58.1, CH | H-12, H-14 | C-1 |
| 14 | 3.34 d (4.0) | 62.7, CH | H-13 | C-1, -10 |
| 15 | 1.20 s | 15.2, CH3 | C-1, -2, -10, -14 | |
| 16a | 4.67 d (15.6) | 64.6, CH2 | H-6, H-16b | C-5, -6 |
| b | 4.80 d (15.6) | H-6, H-16a | C-5, -6 | |
| 17 | 2.39 q (6.8) | 43.7, CH | H3-18 | C-18, -19 |
| 18 | 1.21 d (6.8) | 6.3, CH3 | H-17 | C-8, -17, -19 |
| 19 | 175.6, C | |||
| 20 | 1.08 d (6.8) | 9.7, CH3 | H-11 | C-10, -11, -12 |
| 9-OAc | 169.5, C | |||
| 2.20 s | 21.8, CH3 | Acetate carbonyl | ||
| 12-OAc | 170.3, C | |||
| 2.11 s | 21.0, CH3 | Acetate carbonyl | ||
| 16-OAc | 172.2, C | |||
| 2.19 s | 21.2, CH3 | Acetate carbonyl | ||
| OH-2 | 3.55 br s | H-2 | n. o. | |
| OH-8 | 3.73 br s | n. o. |
a n. o. = not observed.
Figure 1The computer-generated model of 1 using MM2 force field calculations and the calculated distances (Å) between selected protons with key NOESY correlations.
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and 1H–1H COSY and HMBC correlations for briarane 2.
| Position | δH ( | δC, Multiple | 1H–1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 42.1, C | |||
| 2 | 5.51 d (3.6) | 72.5, CH | H-3 | Acetate carbonyl |
| 3 | 4.76 ddd (3.6, 3.2, 3.2) | 72.3, CH | H-2, H2-4 | n. o. |
| 4α | 2.13 m | 33.7, CH2 | H-3, H-4β | C-5 |
| β | 3.31 dd (16.0, 3.2) | H-3, H-4α | C-3 | |
| 5 | 143.2, C | |||
| 6 | 5.53 s | 121.2, CH | H-7, H3-16 | C-4, -5, -8, -16 |
| 7 | 5.53 s | 79.8, CH | H-6 | C-6 |
| 8 | 84.6, C | |||
| 9 | 5.34 d (1.2) | 77.2, CH | H-10 | C-1, -7, -8, -10, -11, -17, |
| acetate carbonyl | ||||
| 10 | 2.96 br s | 43.8, CH | H-9 | C-8, -9, -11, -12, -14 |
| 11 | 131.6, C | |||
| 12 | 5.49 br s | 122.2, CH | H2-13, H3-20 | n. o. |
| 13α | 2.17 m | 28.2, CH2 | H-12, H-13β, H-14 | C-12 |
| β | 2.35 m | H-12, H-13α, H-14 | n. o. | |
| 14 | 4.92 dd (10.0, 7.2) | 73.5, CH | H2-13 | C-2 |
| 15 | 1.59 s | 17.3, CH3 | C-1, -2, -10, -14 | |
| 16 | 1.85 br s | 23.9, CH3 | H-6 | C-4, -5, -6 |
| 17 | 2.91 q (7.2) | 42.1, CH | H3-18 | C-8, -18, -19 |
| 18 | 1.11 d (7.2) | 7.4, CH3 | H-17 | C-8, -17, -19 |
| 19 | 176.1, C | |||
| 20 | 1.79 d (1.2) | 22.2, CH3 | H-12 | C-10, -11, -12 |
| 2-OAc | 169.2, C | |||
| 2.10 s | 21.0, CH3 | Acetate carbonyl | ||
| 9-OAc | 169.8, C | |||
| 2.24 s | 21.0, CH3 | Acetate carbonyl | ||
| 14-OAc | 170.3, C | |||
| 1.98 s | 21.0, CH3 | Acetate carbonyl | ||
| 3-OC(O)CH2CH2CH3 | 172.3, C | |||
| 1′ 2′ 3′ 4′ | 2.21 t (7.6) | 35.9, CH2 | H2-3′ | C-1′, -3′, -4′ |
| 1.60 m | 18.0, CH2 | H2-2′, H3-4′ | C-1′, -2′, -4′ | |
| 0.94 t (7.2) | 13.6, CH3 | H2-3′ | C-2′, -3′ |
a n. o. = not observed.
Figure 2The computer-generated model of 2 using MM2 force field calculations and the calculated distances (Å) between selected protons with key NOESY correlations.
Figure 3Effects of Compounds 1 and 2 on pro-inflammatory iNOS and COX-2 protein expression in the LPS-stimulated murine macrophage cell line, RAW264.7. (A) Relative density of iNOS immunoblot; (B) relative density of COX-2 immunoblot. The relative intensity of the LPS-stimulated group was taken to be 100%. Band intensities were quantified by densitometry and are indicated as the percent change relative to that of the LPS-stimulated group. Compounds 1, 2 and dexamethasone (Dex) significantly inhibited LPS-induced iNOS protein expression in macrophages. The experiment was repeated three times (* p < 0.05, significantly different from the LPS-stimulated group).